Detection of ERBB2 (HER2) Gene Amplification Events in Cell-Free DNA and Response to Anti-HER2 Agents in a Large Asian Cancer Patient Cohort

por Lee, Jeeyun, Franovic, Aleksandra, Shiotsu, Yukimasa, Kim, Seung Tae, Kim, Kyoung-Mee, Banks, Kimberly C., Raymond, Victoria M., Lanman, Richard B.
Publicado 2019

Shikonin, dually functions as a proteasome inhibitor and a necroptosis inducer in multiple myeloma cells

por WADA, NAOKO, KAWANO, YAWARA, FUJIWARA, SHIHO, KIKUKAWA, YOSHITAKA, OKUNO, YUTAKA, TASAKI, MASAYOSHI, UEDA, MITSUHARU, ANDO, YUKIO, YOSHINAGA, KAZUYA, RI, MASAKI, IIDA, SHINSUKE, NAKASHIMA, TAKAYUKI, SHIOTSU, YUKIMASA, MITSUYA, HIROAKI, HATA, HIROYUKI
Publicado 2014

Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinoma

por Koh, Yoko, Nakano, Kosuke, Katayama, Kotoe, Yamamichi, Gaku, Yumiba, Satoru, Tomiyama, Eisuke, Matsushita, Makoto, Hayashi, Yujiro, Yamamoto, Yoshiyuki, Kato, Taigo, Hatano, Koji, Kawashima, Atsunari, Ujike, Takeshi, Imamura, Ryoichi, Yamaguchi, Rui, Imoto, Seiya, Shiotsu, Yukimasa, Nonomura, Norio, Uemura, Motohide
Publicado 2022